Emerging and future therapies for Allergic rhinitis

A. Licari, A. Marseglia, S. Caimmi, A. Ricci, B. Rundo, D. Poddighe, G. L. Marseglia

Research output: Contribution to journalArticle

Abstract

Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. To date, the mainstay of current treatment strategies of AR includes allergen avoidance, pharmacotherapy and allergen-specific immunotherapy, as defined by Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for both adults and children. The aim of this review is to provide an update on all emerging and future therapeutic options for the treatment of AR.

Original languageEnglish
Pages (from-to)38-46
Number of pages9
JournalJournal of Biological Regulators and Homeostatic Agents
Volume29
Issue number2
Publication statusPublished - 2015

    Fingerprint

Keywords

  • Allergic rhinitis
  • Immunotherapy
  • Omalizumab
  • Pharmacotherapy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Physiology
  • Immunology
  • Medicine(all)
  • Oncology
  • Endocrinology
  • Physiology (medical)
  • Cancer Research

Cite this